HOME › DRUGS › SOTAGLIFLOZIN
ACTIVE SUBSTANCE / INN

SOTAGLIFLOZIN

Brand name(s): Zynquista, INPEFA
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
Diabetes Mellitus, Type 1
NDA216203
ACTIVE SUBSTANCE
Sotagliflozin
REGULATORS
FDA · EMA
SPONSORS / MAH
LEXICON PHARMS INC, Guidehouse Germany GmbH
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
INPEFANDA216203LEXICON PHARMS INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ZynquistaGuidehouse Germany GmbHWithdrawn26/04/2019Diabetes Mellitus, Type 1

FULL INTELLIGENCE ON SOTAGLIFLOZIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →